These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1447396)

  • 1. Advances in the diagnosis of adverse drug reactions.
    Naranjo CA; Shear NH; Lanctôt KL
    J Clin Pharmacol; 1992 Oct; 32(10):897-904. PubMed ID: 1447396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicians' Reports in Electronic Health Records Versus Patients' Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin.
    Topaz M; Lai K; Dhopeshwarkar N; Seger DL; Sa'adon R; Goss F; Rozenblum R; Zhou L
    Drug Saf; 2016 Mar; 39(3):241-50. PubMed ID: 26715498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.
    Tegeder I; Levy M; Muth-Selbach U; Oelkers R; Neumann F; Dormann H; Azaz-Livshits T; Criegee-Rieck M; Schneider HT; Hahn E; Brune K; Geisslinger G
    Br J Clin Pharmacol; 1999 May; 47(5):557-64. PubMed ID: 10336581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects.
    Pourpak Z; Fazlollahi MR; Fattahi F
    Recent Pat Inflamm Allergy Drug Discov; 2008 Jan; 2(1):24-46. PubMed ID: 19075990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 8. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes' Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions.
    Oshima S; Enjuji T; Negishi A; Akimoto H; Ohara K; Okita M; Numajiri S; Inoue N; Ohshima S; Terao A; Kobayashi D
    Biol Pharm Bull; 2017 Sep; 40(9):1389-1398. PubMed ID: 28579595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early identification of adverse drug reactions from search log data.
    White RW; Wang S; Pant A; Harpaz R; Shukla P; Sun W; DuMouchel W; Horvitz E
    J Biomed Inform; 2016 Feb; 59():42-8. PubMed ID: 26610385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods and systems to detect adverse drug reactions in hospitals.
    Thürmann PA
    Drug Saf; 2001; 24(13):961-8. PubMed ID: 11735652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized survelliance of adverse drug reactions in hospital: pilot study.
    Azaz-Livshits T; Levy M; Sadan B; Shalit M; Geisslinger G; Brune K
    Br J Clin Pharmacol; 1998 Mar; 45(3):309-14. PubMed ID: 10896407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are non-serious adverse reactions to psychiatric drugs really non-serious?
    Pozzi M; Bertella S; Cattaneo D; Molteni M; Perrone V; Carnovale C; Antoniazzi S; Clementi E; Radice S
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):394-400. PubMed ID: 23952186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.